SAN DIEGO, CA / ACCESSWIRE / May 9, 2024 / Prometheus Laboratories Inc. ("Prometheus"), a leader in precision medicine for immune-mediated diseases, announced the execution of provider agreements with ...
When dosing is optimized, biologics such as IFX are highly effective for managing CD and UC. Anser IFX testing uses a drug-tolerant homogeneous mobility shift assay (HMSA) to provide clinicians ...
SAN DIEGO, Oct. 20 Prometheus Laboratories Inc., a specialty pharmaceutical and diagnostic company, today announced that it has been awarded U.S. Patent No. 7,592,437 by the U.S. Patent and Trademark ...
SAN DIEGO, CA / ACCESS Newswire / August 27, 2025 / Prometheus Laboratories Inc. ("Prometheus"), a leader in precision healthcare, today announced a collaboration with Celltrion USA, Inc. ("Celltrion ...
一部の結果でアクセス不可の可能性があるため、非表示になっています。
アクセス不可の結果を表示する